Dr. Anh Wartel earned her MD at the Paris XII Medical School, France, and completed a post-graduate diploma in Public Health from the University of Liverpool, UK. She is an honorary Professor at the University of Rwanda.
Anh Wartel, M.D., is the Deputy Director General, Regional Director of the IVI Europe
Regional Office, overseeing IVI’s operational, scientific, and technical activities in the Europe region, including the Europe Regional Office in Stockholm and a Country Office in Vienna. She is based in Stockholm, Sweden.
Dr. Wartel joined IVI in 2018 as the Head of Clinical Development and Regulatory, then the Deputy Director General of the Clinical, Assessment, Regulatory, Evaluation (CARE) unit. She has twenty-five years of experience in clinical research.
Before IVI, Dr. Wartel held various positions in epidemiology, clinical R&D, and medical affairs, overseeing multiple clinical developments (e.g., rabies, cholera, typhoid fever, hepatitis A, yellow fever, dengue, Japanese encephalitis vaccines) in pre- and post-licensure stages at Sanofi in Asia for 15 years. She initially started her research career with the French National Agency of Research on HIV/AIDS (ANRS), involved in drug trial projects as an investigator for five years in Paris.